R
Ragwa M. Farid
Researcher at Pharos University in Alexandria
Publications - 32
Citations - 1005
Ragwa M. Farid is an academic researcher from Pharos University in Alexandria. The author has contributed to research in topics: Solid lipid nanoparticle & Niosome. The author has an hindex of 15, co-authored 31 publications receiving 679 citations.
Papers
More filters
Journal ArticleDOI
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges.
Ming Ming Wen,Noha S. El-Salamouni,Wessam M. El-Refaie,Heba A. Hazzah,Mai M. Ali,Giovanni Tosi,Ragwa M. Farid,María J. Blanco-Prieto,Nashiru Billa,Amira Sayed Hanafy +9 more
TL;DR: A review of the recent studies conducted on NTDDS for AD treatment, with a primary focus on the industrial perspectives and processability, highlights the ongoing clinical trials for AD management.
Journal ArticleDOI
Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
TL;DR: Complexation is a promising approach to enhance the entrapment of cationic GH into cATIONic chitosan nanoparticles (CS-NPs) for Alzheimer’s disease management intranasally and has insignificant effect on the physicochemical properties of CS-NBP.
Journal ArticleDOI
A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
Nancy Abdel Hamid Abou Youssef,Abeer Ahmed Kassem,Ragwa M. Farid,Fatma Ahmed Ismail,Magda A. El-Massik,Nabila Boraie +5 more
TL;DR: Results revealed rapid ALM brain delivery of the optimized formula, and toxicological results confirmed the safety of NF for nasal administration, encouraging for further clinical trials of the developed system in humans in future research.
Journal ArticleDOI
Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: Development and characterization.
TL;DR: The obtained results provide an efficient approach for delivering solid lipid nanoparticles in a solid dosage form keeping the nanoparticle characters and integrity.
Journal ArticleDOI
Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.
TL;DR: The pharmacological efficacy and in vivo safety of nasal CX-NP2 confirm their promising potential to contribute to the management of AD intranasally.